Jackson Laboratory

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Boehringer Ingelheim GmbH is closely

Former Ignyta Inc. chief operating officer Zachary Hornby helped the developer of Roche 's now-approved tumor-agnostic therapy Rozlytrek (entrectinib) transition its assets to the Swiss big pharma

Cancer is the second most common cause of death in the US, accounting for one of every four deaths and nearly 1,600 deaths per day in 2014 according to the American Cancer Society. While there are a p

SHANGHAI – In an effort to reverse its fortunes in China, the global preclinical CRO Charles River Laboratories International Inc. has reached an agreement to acquire a 75% stake in licensee Vita